Arcus Biosciences Inc. (RCUS)
NYSE · Healthcare
Arcus Biosciences Inc. EPS 2017–2025
Arcus Biosciences Inc. annual/quarterly eps history and growth rate from 2019 to 2026. Earnings per share (EPS) is a company's net profit divided by the number of diluted shares outstanding. Higher EPS generally indicates greater profitability.
- Arcus Biosciences Inc. eps for the quarter ending March 31, 2026 was $1.02, a 10.53% decrease year-over-year.
- Arcus Biosciences Inc. annual eps for 2025 was $3.29, a 4.78% increase from 2024.
- Arcus Biosciences Inc. annual eps for 2024 was $3.14, a 24.34% decrease from 2023.
- Arcus Biosciences Inc. annual eps for 2023 was $4.15, a 11.86% increase from 2022.
- Arcus Biosciences Inc. annual eps for 2022 was $3.71.
EPS
ANNUAL · USD
QUARTERLY · USD
YEAR-OVER-YEAR GROWTH · %
Arcus Biosciences Inc. EPS — FAQ
Arcus Biosciences Inc. (RCUS) eps over the last 9 years — annual and quarterly figures with year-over-year growth and charts.
What is Arcus Biosciences Inc.'s eps?
Arcus Biosciences Inc. (RCUS) reported eps of $-3.29 for fiscal 2025.
Where can I see RCUS's eps history?
The chart and table above show Arcus Biosciences Inc.'s eps by year and by quarter, including the growth rate.